Human protein tyrosine phosphatase inhibitors and methods of use
US7795444B2 · kind B2 · utility
44Cited by
13References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2007 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Mar 28, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.